Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synnex Names Marshall Witt CFO

RELATED NEWS
Trade SNX now with 

Synnex Corp. (SNX: Quote) said Monday that it has appointed Marshall Witt as Chief Financial Officer, effective April 8.

Witt will be assuming the role from Thomas Alsborg who announced his retirement last year.

Witt brings to Synnex over 25 years of financial experience with publicly traded companies. His experience includes 15 years with FedEx Corp. in progressive financial and operational roles and five years with KPMG LLP as an audit manager for banking and transportation clients. Most recently, Witt was Senior Vice President of Finance and Controller with FedEx Freight, a $5.3 billion subsidiary of FedEx serving the US, Canada and Mexico.

Click here to receive FREE breaking news email alerts for Synnex Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.